STOCK TITAN

electroCore (ECOR) director Errico exercises warrants to acquire 42,055 shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

electroCore, Inc. director Thomas J. Errico exercised warrants to acquire a total of 42,055 shares of common stock, with 22,803 shares exercised at an exercise price of $4.35 per share and 19,252 shares at $6.43 per share.

Following these exercises, his directly owned common stock is reported at 350,071 shares. A footnote explains this includes 259,106 shares owned directly, 1,296 shares held by a family trust, 11,000 shares held by a trust for his benefit, 26,615 unvested shares underlying deferred stock units, and 52,054 shares that have vested from prior deferred stock units.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Errico Thomas J.

(Last)(First)(Middle)
200 FORGE WAY, SUITE 205

(Street)
ROCKAWAY NEW JERSEY 07866

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
electroCore, Inc. [ ECOR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/19/2026X22,803A$4.35330,819D
Common Stock03/19/2026X19,252A$6.43350,071(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrants to Purchase Common Stock$4.3503/19/2026X22,80302/02/202402/02/2029Common Stock22,803$0.000D
Warrants to Purchase Common Stock$6.4303/19/2026X19,25206/05/202406/05/2029Common Stock19,252$0.000D
Explanation of Responses:
1. Includes 259,106 shares owned directly by the RP; 1,296 shares owned by a trust for the benefit of the RP's family; 11,000 shares owned by a trust for the benefit of the RP; 26,615 unvested shares underlying deferred stock units ("DSUs"); and 52,054 shares that have vested pursuant to previously issued DSUs. All such vested shares were previously reported on Form 4 filings at the time of grant.
/s/ John L. Cleary, II, attorney-in-fact03/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did electroCore (ECOR) director Thomas J. Errico report?

Thomas J. Errico reported exercising warrants to acquire 42,055 electroCore common shares. He exercised 22,803 warrants at $4.35 per share and 19,252 warrants at $6.43, converting derivative holdings into directly owned stock without any reported open-market sales.

How many electroCore (ECOR) shares did the director acquire through warrant exercises?

He acquired 42,055 electroCore common shares through warrant exercises. This total consists of 22,803 shares from warrants with a $4.35 exercise price and 19,252 shares from warrants with a $6.43 exercise price, all on March 19, 2026.

What are Thomas J. Errico’s reported electroCore (ECOR) share holdings after the transactions?

After the warrant exercises, his directly owned electroCore common stock is reported at 350,071 shares. A supporting footnote states this total includes direct shares, shares held in family-related trusts, and both vested and unvested deferred stock units linked to prior compensation.

Were any electroCore (ECOR) shares sold in this Form 4 transaction?

The Form 4 shows only exercises of warrants to obtain common stock, with no reported sales. All four transactions are coded as derivative exercises, indicating acquisition of shares rather than open-market buying or selling activity on the transaction date.

What types of securities did electroCore (ECOR) director Errico exercise?

He exercised “Warrants to Purchase Common Stock” that converted into electroCore common shares. Two derivative entries show the warrant exercises, which correspond to two non-derivative entries reporting the newly acquired common stock at exercise prices of $4.35 and $6.43 per share.

How are trusts and deferred stock units reflected in the electroCore (ECOR) Form 4 footnote?

The footnote explains his reported holdings include 1,296 shares in a family trust, 11,000 shares in a personal trust, 26,615 unvested shares underlying deferred stock units, and 52,054 vested DSU-related shares, in addition to 259,106 shares owned directly by the reporting person.
Electrocore

NASDAQ:ECOR

View ECOR Stock Overview

ECOR Rankings

ECOR Latest News

ECOR Latest SEC Filings

ECOR Stock Data

52.41M
5.07M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ROCKAWAY